Eli Lilly has officially entered the elite $1 trillion market-value club, becoming the first pharmaceutical company to reach ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

It’s just the latest landmark for Indianapolis-based Lilly, which was catapulted into the top spot as the world’s largest ...

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

Eli Lilly becomes the first healthcare firm to hit $1T, powered by GLP-1 dominance, surging sales, and strong investor ...

With the strength of sales in GLP-1 weight loss drugs Mounjaro and Zepbound, Eli Lilly is now the first pharmaceutical ...

Eli Lilly hit a $1 trillion valuation for the first time, becoming the only healthcare company to reach the milestone as ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Novo Nordisk (NVO) and Eli Lilly (LLY) stocks are in focus as the duo plan to launch direct sales of weight loss drugs to ...

Eli Lilly & Co. and Novo Nordisk A/S plan to start selling their popular obesity shots to employers through a new approach ...